Delivery Order SPE2DB24D6044-SPE2DB25FLHTL

Award Date 3/26/25
Potential Completion Date 3/27/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,400.71 contract is for the supply of CIPRO 5% suspension, a prescription medication, with a performance period through August 17, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This is a $2,752.87 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CIPRO 5% SUSPENSION 100ML. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,375.52, is a delivery order for a medical product described as "CIPRO 5% SUSPENSION 100ML." The contract has a firm fixed-price pricing type and an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPRO 5% SUSPENSION 100ML. The contract has an ultimate completion date of May 14, 2025 and a ceiling value of $2,568.81. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $2,923.78 firm fixed price contract is for the supply of 4565393427 CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a completion date of August 9, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several significant Indefinite Delivery Contracts (IDCs) with the...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,783.38 firm-fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and was awarded on August 23, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major supplier of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,338.31, is for the delivery of 4560901690 - CIPRO 500 MG TABLET 100S. It is a Firm Fixed Price Delivery Order contract with a completion date of May 12, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,740.54 firm-fixed-price delivery order is for CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award, valued at $2,097.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, with a period of performance through March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,965.92 firm fixed-price delivery order is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product, to support defense and military healthcare programs. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D6044
    Indefinite Delivery Contract
  • SPE2DB24D6044-SPE2DB25FLHTL
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,037.39, is for the supply of CIPRO 5% SUSPENSION 100ML, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 1:33 AM